Efficiency of Crizotinib on an ALK-Positive Inflammatory Myofibroblastic Tumor of the Central Nervous System: A Case Report.

Chennouf, Anas; Arslanian, Elizabeth; Roberge, David; Berthelet, France; Bojanowski, Michel; Bahary, Jean-Paul; Masucci, Laura; Belanger, Karl; Florescu, Marie; Wong, Philip

Chennouf, Anas; Arslanian, Elizabeth; Roberge, David; Berthelet, France; Bojanowski, Michel; Bahary, Jean-Paul; Masucci, Laura; Belanger, Karl; Florescu, Marie; Wong, Philip.

Afiliación

Chennouf A; CRCHUM, Université de Montréal.
Arslanian E; Pathology, Centre Hospitalier de l'Université de Montréal (CHUM).
Roberge D; Department of Oncology, Division of Radiation Oncology, McGill University Health Center.
Berthelet F; Pathology, Centre Hospitalier de l'Université de Montréal (CHUM).
Bojanowski M; Neurosurgery, Centre Hospitalier de l'Université de Montréal (CHUM).
Bahary JP; Radiation Oncology, Centre hospitalier de l'université de Montréal (CHUM) - Hôpital Notre-Dame.
Masucci L; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM).
Belanger K; Hemato-Oncology, Centre Hospitalier de l'Université de Montréal (CHUM).
Florescu M; Hemato-Oncology, Centre Hospitalier de l'Université de Montréal (CHUM).
Wong P; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM).

Cureus ; 9(3): e1068, 2017 Mar 02.

Article en En | MEDLINE | ID: mdl-28409069

Palabras clave

alk; cns; crizotinib; inflammatory myofibroblastic tumor; radiotherapy; response

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2017 Tipo del documento: Article